Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Transvenous Lead extraction (TLE) is the gold standard in the treatment of CIED related infective complications and often required in the management of leads malfunction.HRS and EHRA have published recommendations describing indications, settings, facilities, training and accreditation for transvenous lead extraction procedures.
The registry is sponsored by EHRA
The implant rate of Cardiovascular Implantable Electronic Devices (CIED) continues to rise in most countries. The number of leads per patient is increasing due to a higher proportion of dual versus single chamber devices and an increase of CRTP/D systems. Greater life expectancy, need for upgrade, multiple replacements of generators or pocket revisions for complications expose patients to infections.Despite advances in technology and improvements in reliability, leads remain the weak point of the systems and in some cases may fail.Transvenous Lead extraction (TLE) is the gold standard in the treatment of CIED related infective complications and often required in the management of leads malfunction.HRS and EHRA have published recommendations describing indications, settings, facilities, training and accreditation for transvenous lead extraction procedures.
This is the first large prospective, multicentre, European Controlled Registry of consecutive patients undergoing TLE procedures in European Countries and including a Follow-Up phase.
The primary objective is to evaluate the acute and long-term safety of TLE. Measures: major procedure-related complications (including death) in acute and long-term follow-up.
The secondary objectives of the ELECTRa Registry are:
The information collected in the Survey will allow a description of the European practice on TLE, a comparison of data among centres and Countries, with possible evaluation of:
The recruitment of patients started on November 2012 and ended on May 2014. 79 centres from 19 countries participated in the registry and 3524 consecutive patients have been enrolled and are now being followed up to 1 year.
Preliminary data on TLE in Europe have been presented during the 2014 ESC Congress in Barcelona and final results should be presented during the EHRA EUROPACE - Cardiostim 2015 in Milan.
Please see our publications page for the article on the baseline results.
Several auxiliary analyses are being performed currently.
The Executive Committee is chaired by Dr. Maria Grazia Bongiorni, co-chaired by Dr. Charles Kennergren.
Maria Grazia Bongiorni, ChairCharles Kennergren, Co-chairChristian ButterJean-Claude DeharoAndrzej KutarskiAldo RinaldiAldo Maggioni, EORP Scientific Coordinator, ex-officio (non-voting)Carina Blomström-LundqvistAngelo AuricchioNikolaos Dagres
Most of the Executive Committee members are also regional coordinators for the participating countries.
Maria Grazia Bongiorni (IT,IL,CH,PT)Charles Kennergren (DK,NO,FI,NL,SE)Christian Butter (DE)Jean-Claude Deharo (FR,ES)Andrzej Kutarski (AZ,CZ,GR,HR,LT,PL,RO,RU,SL,UA)Aldo Rinaldi (BE,UK)
View all ongoing ESC Registries
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.